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Background: In Latin America, few studies have been carried out on methicillin-resistant
Staphylococcus aureus carriage in the pediatric population. We  conducted a survey of nasal
S.  aureus carriage in neonates and in children attending the pediatric outpatient clinics in a
large Brazilian city with high antimicrobial consumption.
Methods: Pernasal swabs of neonates were collected upon admission and at discharge in four
neonatal intensive care units and of children less than ﬁve years of age during outpatient
visits.  Methicillin-resistant S. aureus isolates were characterized for antibiotic susceptibil-
ity,  mec gene presence, pulsed-ﬁeld gel electrophoresis, spa type, SCCmec-type, multilocus
sequence  type, and presence of Panton-Valentine leukocidin genes.
Results:  S. aureus was carried by 9.1% and 20.1% of the 701 neonates and of 2034 children
attending  the outpatient clinics, respectively; methicillin-resistant S. aureus carriage was
detected  in 0.6% and 0.2%, of the these populations, respectively. Healthcare-associated
methicillin-resistant S. aureus strains found in neonates from neonatal intensive care units
and  outpatients were genetically related to the Brazilian (SCCmec-III, ST239) and to the
Pediatric  (SCCmec-IV, ST5) clones. Community-associated methicillin-resistant S. aureus was
only detected in outpatients. None of the methicillin-resistant S. aureus strains contained
the  Panton-Valentine leukocidin gene. Methicillin-resistant S. aureus strains related to the
Brazilian clone showed multidrug resistance pattern.
Conclusions: Despite the high antibiotic pressure in our area, and the cross transmission ofiatedthe healthcare-assoccare units and outpatient
low  in our setting.
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taphylococcus aureus is a common cause of community and
ealthcare-associated illness. Carriage of S. aureus is frequent
n  children and the anterior nares are the most consis-
ent  site for S. aureus colonization.1 Children colonized with
ethicillin-resistant S. aureus (MRSA) are potential reservoirs
or  the spread of MRSA in the community.2,3 The relationship
etween MRSA nasal carriage and invasive staphylococcal
nfection has been well documented.4 A limited number of
RSA  clonal lineages has been responsible for the majority of
RSA  infections in several regions.
Since the emergence and rapid spread of community-
ssociated MRSA (CA-MRSA) in previously healthy hosts,5
ttention has been given to studies reporting changes in the
pidemiology  of MRSA colonization especially CA-MRSA in
ospitalized  patients6 and healthcare-associated MRSA (HA-
RSA)  in healthy subjects.7,8
In neonatal intensive care units (NICUs), neonates are at
igh  risk for MRSA infections. Patients colonized by MRSA in
ICUs present signiﬁcant rates of bloodstream infection9 and
re  often transferred to other hospitals, contributing to the
pread  of MRSA in health facilities. Studies on MRSA carriage
n  neonates, however, are usually conducted under outbreak
ituations  in NICUs.10,11
Despite the severity and rapid global expansion of MRSA
trains,  the epidemiology of MRSA nasal carriage remains
nclear. In Latin America, few molecular studies are available
n  MRSA carriage in the pediatric population.12,13 To deter-
ine  the extent the nasal carriage of MRSA is widespread in
he  pediatric population, we carried out a survey in neonates
nd  in outpatient children in a large Brazilian city. We inves-
igated  molecular characteristics of MRSA isolates.
aterials  and  methods
tudy  area
he study was  conducted in the municipality of Goiânia, cap-
tal  of Goiás state, located in Central Brazil, a region with
igh  rates of antibiotics consumption (Andrade 2012). In the
010  census, the population of Goiânia was  estimated at
,302,001  inhabitants, with 20,014 live births, infant mortality
t  14.6 deaths per 1000 live births, and 84,465 children under
ve  years.14 Public health care is provided free of charge by
he  Brazilian Uniﬁed Health System, and an estimated 75%
f  the population use the public health system.15 In Goia-
ia,  children are ﬁrst seen at the public healthcare centers
pediatric outpatient clinics) and referred to hospitalization
henever necessary. For this study, two pediatric populations
ere  screened for MRSA, as described below.
eonates  admitted  to  NICUsrom June 2007 through November 2008 were screened for
RSA  carriage all neonates admitted to four NICUs, which
ttend  children from public and private health insurance. Tak-
ng  together these NICUs comprise the majority of beds (n = 69) 1 4;1  8(1):42–47  43
for  neonates in the city. Data were collected on demograph-
ics  (gender, date of birth, and age at NICU admission), each
neonate’s  clinical history (length of hospital stay, congenital
malformation, birth weight, preterm, timing of swab collec-
tion,  nasogastric intubation, and diagnoses upon admission
and  at discharge), and variables related to their mothers (type
of  delivery, schooling, number of prenatal visits, and placental
abruption).
Outpatient  children
The carriage survey was  conducted from July 2007 through
July  2008 in children less than ﬁve years of age attending the
major  outpatient clinic of the city, served by the Brazilian pub-
lic  health insurance (Brazilian Uniﬁed Health System). Data
were  collected on child (gender, age, congenital malforma-
tion,  skin and soft-tissue infections, hospitalization in the last
six months, antibiotic use in the last three months, day care
attendance  in the last six months, acute otitis media in the
last  12 months, pneumonia in the last 12 months, and tonsil-
litis  in the last 12 months) and the family (mother’s schooling,
smoking  at home, number of family members, and health
worker  in the family). We calculated that a sample size of
2000  children would be necessary to ascertain MRSA preva-
lence  assuming a 1.2% prevalence of MRSA nasal carriers16
with a 95% conﬁdence interval (95% CI), a precision of 0.7%,
design  effect of 1.8, and a refusal rate of 10%. The number
of  children who were recruited at the outpatient clinics per
day  took into account the laboratory capability for processing
nasal  specimens (approximately 10 swabs/day).
Collection  of  nasal  specimens
Pernasal ﬂocked swabs were collected by rotating the swab
twice  in the vestibule of the anterior nostrils of each child.
In  the outpatients, a single sample was collected from each
child.  At the NICUs, two samples were collected per child; the
ﬁrst  collected upon admission and the second at discharge
or  death. After collection, the swabs were placed in a liquid
medium  (ESwab, Copan Diagnostics, Inc., Murrieta, CA, USA)
and  sent to the Microbiology Laboratory of the Federal Univer-
sity  of Goiás for immediate processing.
Study  ethics
The Institutional Review Board approval was  given by the
Ethics  Committee of the Federal University of Goiás (#
008/2007). All parents or legal guardians signed copies of the
informed  consent form before recruitment.
Microbiological  techniques
The specimens were  plated onto mannitol salt agar (Difco®
Laboratories Inc., Detroit, MI,  USA) for S. aureus isolation. Tryp-
ticase  soy agar plates, which were  supplemented with 4% NaCl
and  oxacillin at 6 g/mL, were  used to screen MRSA isolates.
After  24–48 h of incubation at 37 ◦C, the colonies that were  sus-
pected  of being S. aureus were conﬁrmed by Gram staining,
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Table 1 – Characteristics of children screened for
Staphylococcus aureus and MRSAa nasal colonization.
Goiânia, Brazil, 2007–2008.
Variables n/total (%)
Neonatal intensive care units (n = 710)b
Male 409/709 (57.6)
Age at admission < 24 h 519/701 (74.0)
Low birthweight 393/704 (56.5)
Mother’s schooling ≤ 8 years 260/680 (36.6)
Congenital malformation 117/702 (16.5)
Frequency of prenatal visits ≤ 6 418/663  (58.9)
Cesarean section 438/704  (61.7)
Premature birth 454/687  (63.9)
Intubation 374/690 (52.7)
Nasogastric tube 257/688 (36.2)
Emergency department (n = 2034)
Males 1108/2034 (54.5)
Age ≥ 24 months 784/2034 (38.5)
Congenital malformation 69/2031 (3.4)
Skin and soft-tissue infections in
the last 12 months
570/2033  (28.0)
Acute otitis in the last 12 months 752/2034 (37.0)
Pneumonia in the last 12 months 623/2033 (30.6)
Tonsillitis in the last 12 months 1139/2033 (56.0)
Hospitalization in the last 6
months
586/2031  (28.8)
Antibiotic use in the last 3
months
948/1821  (46.6)
Day care attendance in the last 6
months
388/2033 (19.1)
Mother’s schooling ≤ 8 years 893/2028 (43.9)
Smoking at home 695/2033 (34.2)
Health worker in the family 109/2034 (5.4)
Number of family members > 4 676/2031 (33.2)44  b r a z j i n f e c t d
catalase, coagulase, and PCR ampliﬁcation of the femB gene
(Jonas  1999).
Antimicrobial  susceptibility  testing
Susceptibility tests were  determined by disk diffusion (Oxoid
Ltd.,  Basingstoke, Hampshire, England) for oxacillin, cefox-
itin,  clindamycin, ciproﬂoxacin, erythromycin, rifampicin,
tetracycline, trimethoprim–sulfamethoxazole, linezolid, and
quinupristin/dalfopristin according to the Clinical Laboratory
Standards Institute guideline.17 Isolates resistant to cefoxitin
and  oxacillin were  submitted to the Etest® (AB Biodisk, Slona,
Sweden)  to determine the sensitivity to vancomycin. S. aureus
strains  ATCC 25923 and ATCC 29213 were  used as quality con-
trols.
MRSA  deﬁnition
Isolates showing inhibition zones of ≤10 mm and ≤21 mm
around  1 mg  oxacillin (Oxoid, Cambridge, UK) and 30 g cefox-
itin  (Oxoid, Cambridge, UK) disks, respectively, and that were
positive  for mecA gene by PCR, were characterized as MRSA.
Molecular  typing
Detection of mecA gene and SCCmec types were investigated
by  multiplex PCR18 using COL (SCCmec type I), N315 (SCCmec
type  II), ANS46 (SCCmec type III), and MW2  (SCCmec type IV) as
positive controls. Multilocus sequence typing was carried out
as previously reported19 and submitted to the international
database (http://www.mlst.net) to assign the sequence type
(ST). Sequencing of the polymorphic X region of the protein
A  gene (spa) and the Panton-Valentine leukocidin (PVL) gene
were  performed as described elsewhere.20,21 The sequences
were  analyzed using the Ridom Staph Type software (Ridom,
Germany)  to determine the spa types. The following inter-
national  MRSA clones were  included as controls: ST5-II
(New-York/Japan, USA100), ST239-III (Brazilian/Hungarian),
ST5-VI (Pediatric, USA800), and ST22-IV (EMRSA-15). The
clonal  relatedness was investigated by pulsed-ﬁeld gel elec-
trophoresis  (PFGE) with SmaI macrorestriction according to
standard procedures.22 The PFGE patterns were interpreted
according to the criteria proposed by Tenover et al.,23 and the
resulting  dendrogram was  constructed using Dice coefﬁcients
with  BioNumerics software (version 5.0). Isolates were  deﬁned
as  epidemiologically related if they shared ≥80% similarity on
the dendrogram.
Data  analysis
Prevalence of MRSA and the corresponding 95% conﬁdence
interval (95% CI) were  calculated. Multidrug resistance (MDR)
was  deﬁned for isolates with resistance to three classes of
antimicrobials and to -lactams. Moving-average was  used to
calculate the percentage of colonization by S. aureus; the value
attributed  to a given month was  the average colonization in
that month, and the ones of the months prior and after the
given  month. Differences in lengths of stay in NICUs betweena Methicillin-resistant Staphylococcus aureus.
b The total does not always equals to 710.
neonates colonized and non-colonized by MRSA strains were
evaluated  by the Mann–Whitney test.
Results
Neonates
During the study period, a total of 710 neonates were  admit-
ted  to the four NICUs, and nasal swabs were obtained from
701  (98.7%) of them. The characteristics of the neonates and
their  mothers are described in Table 1.The overall preva-
lence  of S. aureus and MRSA was  9.1% (95% CI 7.2–11.4) and
0.6%  (95% CI 0.2–1.4), respectively, and varied among the
NICUs  (Table 2). Four neonates carried MRSA strains; three of
them  acquired MRSA during the hospitalization period and
had  higher lengths of stay (median = 20 days) compared to
neonates  who were non-colonized by MRSA (median = 10 days)
(p = 0.072).
Children  attending  the  outpatientsA total of 2034 children were enrolled for nasal swabbing dur-
ing  the study period. The mean age of the children was  21.6
months  (SD = 16.0), and 31.8% of them had less than 12 months
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Table 2 – Prevalence of Staphylococcus aureus and methicillin-resistant S. aureus carriage according to the neonatal
intensive care unit.
Neonatal intensive care units S. aureus MRSA
n % (95% CI) n % (95% CI)
#1 (n = 93) 5 5.4 (2.0–11.5) 0 0.0 –
#2 (n = 80) 2 2.5 (0.4–8.0) 0 0.0 –
#3 (n = 426) 41 9.6 (7.1–12.7) 2 0.5 (0.1–1.5)
(9.6–23.7) 2 2.0 (0.3–6.3)
(7.2–11.4) 4 0.6 (0.3–1.6)
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Fig. 1 – Age-related prevalence of Staphylococcus aureus
colonization by age. Each dot represents a child colonized
by  S. aureus. Vertical arrows indicate the age of child
colonized by the corresponding HA-MRSA and CA-MRSA
clones.
F
c
N
C
c#4 (n = 102) 16 15.7 
Total (n = 701) 64 9.1 
f age. The main clinical features of the participant children
re  shown in Table 1. Four hundred and eight children (20.1%;
5%  CI: 18.4–21.9%) were colonized by S. aureus. Colonization
y  S. aureus showed an age-related distribution, with peak
revalence at 47 months of age (Fig. 1). Four children (0.2%;
5%  CI: 0.1–0.5%) carried MRSA strains.
ntimicrobial  resistance  of  MRSA  isolates
e  identiﬁed 16 MRSA isolates from eight children. Six
hildren  had more  than one isolate. MDR MRSA isolates
ere  found in three children. Eleven MRSA isolates did not
eet  criteria for MDR, but they were resistant to differ-
nt  classes of antibiotics. MRSA isolates showed resistance
o  erythromycin (43.8%), clindamycin (37.5%), ciproﬂoxacin
25.0%) and trimethoprim–sulfamethoxazole (18.8%). All
RSA  strains were  susceptible to vancomycin.
RSA  molecular  ﬁndings
he majority of the MRSA strains clustered into two genomic
roups;  within each group we  identiﬁed children from
oth,  NICUs and outpatient clinics carrying MRSA strains
enetically related to classical pandemic HA-MRSA Brazil-
an  (SCCmec-III, ST239) and Pediatric (SCCmec-IV, ST5) clones
Fig.  2). CA-MRSA strains were  only detected in outpatient
hildren and were clonally related to Western Australian 1
lone/WA-1 (SCCmec-IV, ST128). Only the HA-MRSA Brazilian
lone  showed MDR  pattern. None of the MRSA strains con-
ained  the PVL gene.
BR936
ID Center
Date of swabs Previous
MIC MDR SCCmechospitalizationcollection
Outpatient
NICU - 1
05.14.08
06.05.08
08.03.07
06.15.08
07.22.08
02.14.08
11.21.08
08.29.07Outpatient
NICU - 2
Outpatient
Outpatient
NICU - 2
NICU - 1
BR902
BR415
HU25
BR1419
BR2044
BR682
BR811
HDE288
BR457
NA
NA
NA
NA NA NA
NA
NA
NA NANANA
No No
No
No
No
No
Yes
Yes Yes
Yes
Yes
Yes
>256
>256
>256
>256
24
24
16
16
8
III
III
III
III
IV
IV
IV
IV
IV
IV
(–)
(–)
(–)
(–)
(–)
(–)
(–)
(–)
2223 t037
t037
t037
t037
t128
t128
t045
t045
t002
t002
585
770
239
641
5
5
1
1
5
SLV - HU25
SLV - HU25
SLV - HU25
Brazilian
Western Australian (WA - 1)
Western Australian (WA - 1)
Pediatric (USA800)
Pediatric (USA800)
Pediatric (USA800)
Pediatric (USA800)
94.4
% of similarity
91.7
87.6
76.9
83.9
80.3
100.0
100.0
80 85 90 95 10
0
75
PVL MLST CloneSpa
type
ig. 2 – Molecular characteristics of the 8 MRSA strains from neonates admitted to neonatal intensive care units and
hildren who  visited the outpatient clinics. HDE288, representative Pediatric clone; HU25, representative Brazilian clone;
ICU-1, neonatal intensive care unit of the Santa Bárbara Hospital; NICU-2, neonatal intensive care unit of the Hospital da
rianc¸a; NA, does not apply; MIC, minimum inhibitory concentration; MDR, multidrug-resistant; SCCmec, staphylococcal
assette chromosome mec;  PVL, Panton-Valentine leukocidin; MLST, multilocus sequence type; SLV, single locus variant.
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Discussion
Despite evidence that the MRSA incidence is increasing world-
wide,  studies on MRSA carriage in Latin America are still
scarce.  This study provides information on S. aureus and MRSA
nasal  carriage in outpatient children and in neonates admit-
ted  to NICUs in an urban area of Brazil with high antimicrobial
pressure and infection control lapses.
We found that the frequency of S. aureus by age in chil-
dren  attending outpatients resembled a “J” curve, with higher
prevalence  in infants less than six months of age and in
children  older than 30 months of age. This result is consis-
tent  with studies by Bogaert et al.,24 which reported similar
shape  of age distribution of S. aureus carriage in healthy chil-
dren.
The  rates of MRSA carriage in NICUs herein were lower
compared to studies from the US, Israel, and Taiwan.9,11,25 One
possible  explanation for the low MRSA carriage rate is that the
present  investigation was  performed out of an outbreak, while
the  majority of studies in NICUs are usually conducted as a
result  of an outbreak of MRSA infection.
We also found lower prevalence of MRSA nasal coloniza-
tion  in outpatients when comparing to reports in children
attending well-child health care services in the US3 and in
Taiwan.26 Our ﬁndings, however, were  comparable to those
obtained  in Southern Israel, where the prevalence of MRSA
carriage  in healthy infants aged 2–12 months ranged from
0.0%  to 0.7%.27 Previous investigation in Brazil conducted in
outpatient  children16 detected a higher prevalence of MRSA
nasopharyngeal carriage (1.0%) than that found in the cur-
rent  study (0.2%), possibly because in the previous study the
nasopharyngeal specimens were  obtained during the win-
ter  period, when bacterial colonization of respiratory tract is
expected to be higher compared to colonization rates obtained
from  non-seasonal periods. Nevertheless, comparison of our
results on MRSA carriage with other studies is not straight-
forward due to differences in study designs, inclusion criteria,
epidemiological scenarios, and age groups.
Despite the low colonization rates by MRSA found herein,
this  might turn out to be a serious concern. We identiﬁed three
pandemic  clones of MRSA (Brazilian, Pediatric, and WA1).
The  CA-MRSA WA-1 clone, detected in outpatients, has been
identiﬁed  in patients with bloodstream infections from South
and  Southeast regions of Brazil,28 indicating the dissemina-
tion  of this clone across the country. The HA-MRSA Brazilian
clone  was  detected in an outpatient child. This clone has
been  disseminated through hospitals in many countries of
Latin  America.29 Previously, we described the presence of the
Brazilian  clone in healthy children.16 In all these cases, the
children  had been admitted to hospitalization in the previous
six  months.
One interesting ﬁnding of this study is the presence of the
HA-MRSA  Pediatric clone recovered from outpatient children.
This  clone has been identiﬁed in hospitals of the Southeast
and  Northeast Regions of Brazil30,31 but this is the ﬁrst detec-
tion  of the Pediatric clone in Central Brazil, suggesting that
this  clone is settling in Brazilian hospitals. This observation
conﬁrms that the Pediatric clone is spread in the community,
increasing the chances of expanding its reservoir. 0 1 4;1  8(1):42–47
Some limitations of our study should be mentioned. First,
as  we collected nasal swabs of neonates only at admittance
and  discharge, we were not able to evaluate children who were
intermittently colonized by MRSA in NICUs. Second, the small
number  of MRSA isolates resulted in an insufﬁcient precision
of  the prevalence rates of MRSA carriage. Third, in outpatients,
we  did not enroll children aged higher than ﬁve years of age,
as  the peak of MRSA carriage is expected to be at 11 years of
age.24
In conclusion, we found low rates of MRSA carriage among
children in an area with high antimicrobial pressure. However,
we  detected CA-MRSA, and HA-MRSA clones in the commu-
nity,  which could contribute for an invisible MRSA reservoir,
requiring a close monitoring of the MRSA epidemiology in both
community  and healthcare environment.
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